Figure S3 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma

Abstract

<p>Supplemental Figure 3: Characterization of tumor-infiltrating T cells at the end of experiment (A673 xenografts).</p>